======= TUBB4B ======= == Gene Information == * **Official Symbol**: TUBB4B * **Official Name**: tubulin beta 4B class IVb * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10383|10383]] * **UniProt**: [[https://www.uniprot.org/uniprot/P68371|P68371]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TUBB4B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TUBB4B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602660|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain. |Tubulin C| |Tubulin| |MHC class I protein binding| |natural killer cell mediated cytotoxicity| |natural killer cell mediated immunity| |leukocyte mediated cytotoxicity| |extracellular vesicle| |double-stranded RNA binding| |cell killing| |azurophil granule lumen| |ciliary basal body-plasma membrane docking| |structural constituent of cytoskeleton| |G2/M transition of mitotic cell cycle| |unfolded protein binding| |cell cycle G2/M phase transition| |organelle localization by membrane tethering| |membrane docking| |regulation of G2/M transition of mitotic cell cycle| |regulation of cell cycle G2/M phase transition| |lymphocyte mediated immunity| |mitotic cell cycle phase transition| |cell cycle phase transition| |microtubule| |GTPase activity| |cilium assembly| |cytoskeleton| |cilium organization| |GTP binding| |regulation of mitotic cell cycle phase transition| |plasma membrane bounded cell projection assembly| |regulation of cell cycle phase transition| |cell projection assembly| |microtubule cytoskeleton organization| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |organelle localization| |myeloid leukocyte activation| |mitotic cell cycle process| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulation of mitotic cell cycle| |microtubule-based process| |mitotic cell cycle| |regulated exocytosis| |regulation of cell cycle process| |organelle assembly| |innate immune response| |leukocyte mediated immunity| |exocytosis| |leukocyte activation| |defense response to other organism| |cell cycle process| |secretion by cell| |export from cell| |cell activation| |immune effector process| |cytoskeleton organization| |plasma membrane bounded cell projection organization| |secretion| |cell projection organization| |regulation of cell cycle| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |cell cycle| |defense response| |immune response| |extracellular region| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-3.13| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-3.02| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.97| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-1.81| |[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|1.85| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|2.72| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|3.75| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|5.57| ^Gene^Correlation^ |[[:human genes:v:vbp1|VBP1]]|0.437| |[[:human genes:s:ska1|SKA1]]|0.405| Global Fraction of Cell Lines Where Essential: 39/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|5/28| |blood|1/28| |bone|0/26| |breast|1/33| |central nervous system|1/56| |cervix|0/4| |colorectal|2/17| |esophagus|1/13| |fibroblast|0/1| |gastric|2/16| |kidney|1/21| |liver|1/20| |lung|3/75| |lymphocyte|0/16| |ovary|1/26| |pancreas|4/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|1/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|5/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3902 * **Expression level (log2 read counts)**: 8.46 {{:chemogenomics:nalm6 dist.png?nolink |}}